Continue Reading
Full article on Yahoo Finance
Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing
Market Intelligence Analysis
AI-Powered 60% FREE-ANALYSIS-RULE-BASED-ANALYSIS
Why This Matters
Analysis of stock market developments showing bullish sentiment.
Sentiment
Bullish
AI Confidence
60%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
GARDEN CITY, N.Y., June 01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients’ lives, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to continue its listing on The Nasdaq Stock Market, subject to regaining compliance with the Nasdaq Stock Market LLC’s (“Nasdaq” or the “Exchange”) Listing Rule 5550(a)(2) (t
AI Evidence
What our AI predicted from this news — tracked and scored against the real market move.
Pending evaluation
Logged at publication, scored automatically once the window closes — never edited.
AI Breakdown
Summary
Analysis of stock market developments showing bullish sentiment.
Time Horizon
Short Term
Original article published by
Yahoo Finance
on June 1, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.